Update on COVID-19
* Update valid as of 7th July 2020
- Number of tests: 14934
- Results received: 14903
- Results pending:31
- Confirmed cases: 179
- Recovered cases:176
- Active cases (Gibraltar): 2
- Active cases(non-resident): 1
- Deaths: 0
For previous Gibraltar statistics, click here.
- COVID-19 Tests to be Made Available to the Public
- Update and advice for visitors to St Bernard’s Hospital.
- Contact Tracing Privacy Notice
- Changes to Golden Hour and Silver Time
- Dexamethosone as a COVID-19 treatment
- Shielding to protect the vulnerable
- Information for Close Contacts- Contact Tracing Guidance
- General Guidance for Workplaces and Businesses
If you live in Spain and want to further information on COVID-19, see Junta de Andalucia.
More than 9 million cases of COVID-19 and over 450,000 deaths have now been reported to WHO.
For the latest WHO situation report and global statistics, see here.
A WHO scientific brief on the off-label use of medicines for COVID-19 suggests a number of medicines may provide potential investigational therapies. WHO has also released a Medical Product Alert that warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat or cure COVID-19.
Updates to the WHO COVID-19 information dashboard that allow access to current and reliable data on COVID-19 cases submitted directly to WHO by countries can be found here.WHO has online courses via its interactive, web-based, knowledge-transfer platform to improve the response to health emergencies. Courses in additional languages are also available.
Scientists at Public Health England (PHE) are supporting the scientific community to trace the source of the virus, how it has developed and interventions to help treat it. PHE has developed further specific tests in partnership with WHO and a global network of laboratories; currently, PHE Porton Down researchers have collaborated with colleagues at Liverpool and Bristol universities to develop ‘synthetic virus’ – an exact replica of the actual virus for use in the laboratory.This will enable PHE to continue working with world-leading academic and pharmaceutical partners to accelerate progress towards safe and effective interventions to limit the impact of this new infection as rapidly as possible.Read more here.